Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schnittger

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Leukemia|May 28, 2015
Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicineN Chatain, R C Perera, G Rossetti, et al.
Blood Cancer Journal|September 4, 2012
Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemiaV Grossmann, U Bacher, A Kohlmann, et al.
Leukemia|September 23, 2015
Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletionsS Volkert, T Haferlach, J Holzwarth, et al.
Haematologica|February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotypingC Wuchter, R Ratei, G Spahn, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Leukemia|October 12, 2013
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patientsS Jeromin, S Weissmann, C Haferlach, et al.
Leukemia|February 6, 2009
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic featuresT Haferlach, A Kohlmann, H-U Klein, et al.
Leukemia|March 23, 2013
Landmark analysis of DNMT3A mutations in hematological malignanciesA Roller, V Grossmann, U Bacher, et al.
Leukemia|August 12, 2014
WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroupsM-T Krauth, T Alpermann, U Bacher, et al.
British Journal of Haematology|May 8, 1999
Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcomeF Griesinger, M Pirò-Noack, N Kaib, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Leukemia|May 28, 2015
Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicineN Chatain, R C Perera, G Rossetti, et al.
Blood Cancer Journal|September 4, 2012
Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemiaV Grossmann, U Bacher, A Kohlmann, et al.
Leukemia|September 23, 2015
Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletionsS Volkert, T Haferlach, J Holzwarth, et al.
Haematologica|February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotypingC Wuchter, R Ratei, G Spahn, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Leukemia|October 12, 2013
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patientsS Jeromin, S Weissmann, C Haferlach, et al.
Leukemia|February 6, 2009
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic featuresT Haferlach, A Kohlmann, H-U Klein, et al.
Leukemia|March 23, 2013
Landmark analysis of DNMT3A mutations in hematological malignanciesA Roller, V Grossmann, U Bacher, et al.
Leukemia|August 12, 2014
WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroupsM-T Krauth, T Alpermann, U Bacher, et al.
British Journal of Haematology|May 8, 1999
Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcomeF Griesinger, M Pirò-Noack, N Kaib, et al.
Pageof 14